Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2002 2
2003 1
2004 4
2005 5
2006 3
2007 1
2008 2
2009 1
2010 1
2011 2
2012 1
2013 1
2014 9
2015 4
2016 5
2017 6
2018 6
2019 9
2020 7
2021 7
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H; IBD guidelines eDelphi consensus group; Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB. Lamb CA, et al. Among authors: gaya dr. Gut. 2019 Dec;68(Suppl 3):s1-s106. doi: 10.1136/gutjnl-2019-318484. Epub 2019 Sep 27. Gut. 2019. PMID: 31562236 Free PMC article. Review.
Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition.
Svolos V, Hansen R, Nichols B, Quince C, Ijaz UZ, Papadopoulou RT, Edwards CA, Watson D, Alghamdi A, Brejnrod A, Ansalone C, Duncan H, Gervais L, Tayler R, Salmond J, Bolognini D, Klopfleisch R, Gaya DR, Milling S, Russell RK, Gerasimidis K. Svolos V, et al. Among authors: gaya dr. Gastroenterology. 2019 Apr;156(5):1354-1367.e6. doi: 10.1053/j.gastro.2018.12.002. Epub 2018 Dec 11. Gastroenterology. 2019. PMID: 30550821 Free article. Clinical Trial.
Reply.
Gerasimidis K, Svolos V, Nichols B, Papadopoulou R, Quince C, Ijaz UZ, Milling S, Gaya DR, Russell RK, Hansen R. Gerasimidis K, et al. Among authors: gaya dr. Gastroenterology. 2019 Oct;157(4):1161-1162. doi: 10.1053/j.gastro.2019.08.015. Epub 2019 Aug 10. Gastroenterology. 2019. PMID: 31408620 No abstract available.
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
Kennedy NA, Heap GA, Green HD, Hamilton B, Bewshea C, Walker GJ, Thomas A, Nice R, Perry MH, Bouri S, Chanchlani N, Heerasing NM, Hendy P, Lin S, Gaya DR, Cummings JRF, Selinger CP, Lees CW, Hart AL, Parkes M, Sebastian S, Mansfield JC, Irving PM, Lindsay J, Russell RK, McDonald TJ, McGovern D, Goodhand JR, Ahmad T; UK Inflammatory Bowel Disease Pharmacogenetics Study Group. Kennedy NA, et al. Among authors: gaya dr. Lancet Gastroenterol Hepatol. 2019 May;4(5):341-353. doi: 10.1016/S2468-1253(19)30012-3. Epub 2019 Feb 27. Lancet Gastroenterol Hepatol. 2019. PMID: 30824404
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial.
Danese S, Vermeire S, D'Haens G, Panés J, Dignass A, Magro F, Nazar M, Le Bars M, Lahaye M, Ni L, Bravata I, Lavie F, Daperno M, Lukáš M, Armuzzi A, Löwenberg M, Gaya DR, Peyrin-Biroulet L; STARDUST study group. Danese S, et al. Among authors: gaya dr. Lancet Gastroenterol Hepatol. 2022 Apr;7(4):294-306. doi: 10.1016/S2468-1253(21)00474-X. Epub 2022 Feb 1. Lancet Gastroenterol Hepatol. 2022. PMID: 35120656 Clinical Trial.
Practical guidance on the use of faecal calprotectin.
Brookes MJ, Whitehead S, Gaya DR, Hawthorne AB. Brookes MJ, et al. Among authors: gaya dr. Frontline Gastroenterol. 2018 Apr;9(2):87-91. doi: 10.1136/flgastro-2016-100762. Epub 2017 Feb 22. Frontline Gastroenterol. 2018. PMID: 29588834 Free PMC article. Review.
Ustekinumab improves health-related quality of life in patients with moderate-to-severe Crohn's disease: Results up to Week 104 of the STARDUST trial.
Panés J, Vermeire S, D'Haens GR, Danese S, Magro F, Nazar M, Le Bars M, Lahaye M, Ni L, Bravatà I, Gaya DR, Peyrin-Biroulet L, Dignass A; STARDUST study group. Panés J, et al. Among authors: gaya dr. United European Gastroenterol J. 2023 Jun;11(5):410-422. doi: 10.1002/ueg2.12384. Epub 2023 May 4. United European Gastroenterol J. 2023. PMID: 37139642 Free PMC article. Clinical Trial.
COVID-19: Colorectal cancer endoscopic surveillance in IBD.
Din S, Gaya DR, Arnott IDR. Din S, et al. Among authors: gaya dr. Lancet Gastroenterol Hepatol. 2021 Jul;6(7):526-527. doi: 10.1016/S2468-1253(21)00168-0. Lancet Gastroenterol Hepatol. 2021. PMID: 34119037 Free PMC article. No abstract available.
79 results